Seguridad: hemograma, funcin heptica/renal, no se ha establecido toxicidad significativa hasta 1000 dosis efectiva en estudios subcrnicos
So at a BMI of 30, youre eligible for this drug if youve tried diet and exercise, which just about everybody will have, and you havent been successful with that alone
Maybe the accountability
Specialist hepatologists may occasionally prescribe off-label in exceptional circumstances, particularly for patients with biopsy-proven NASH and significant fibrosis, but this is not routine practice
One drug isnt better than the other, but semaglutide (the active ingredient in Wegovy and Ozempic) targets a single potent pathway (the GLP-1 receptor), while retatrutide is a triple-agonist, acting on GLP-1, GIP, and glucagon receptors